ArticleMikrochimica acta2025
Illuminating NF-KB p50 detection: a cascaded electrochemiluminescent biosensor powered by T7 RNA polymerase transcription and DSN-mediated cleavage on an MXene interface.
Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Early and sensitive detection of transcription factors such as NF-κB p50 is essential for accurate disease diagnosis and monitoring. We present a highly sensitive electrochemiluminescence (ECL) biosensor for the detection of NF-κB p50, integrating a multifunctional nanocomposite and a three-enzyme signal amplification cascade. The sensing platform is constructed by modifying a glassy carbon electrode with a nanocomposite composed of gold nanoparticles (AuNPs), Ti₃C₂Tₓ MXene, and a Ru(II)-polyethylenimine (PEI) complex, which enables strong and stable ECL emission and efficient probe immobilization. The detection mechanism combines Exonuclease III (Exo III)-mediated target recycling, T7 RNA polymerase-driven transcription, and duplex-specific nuclease (DSN)-facilitated signal amplification. Upon binding of NF-κB p50 to the DNA probe, the T7 promoter is exposed, initiating transcription of abundant RNA strands. These RNAs subsequently act as templates for DSN to cleave Fc-labeled DNA on the electrode surface, releasing quenching tags and restoring the ECL signal. The proposed biosensor exhibits excellent analytical performance, including a wide dynamic range (1 aM-10, pM), a low detection Limit of 0.273 aM, and high specificity against interfering proteins. It also demonstrates strong anti-interference capability and satisfactory recovery in diluted cell lysate samples. This work provides a versatile and scalable biosensing strategy with great potential for clinical diagnostics, real-time disease monitoring, and broader biomarker detection in complex biological matrices.
Indexed as
Identifiers
40986086What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.